NCT07252531 (BRIOLIFE) is a NA clinical trial of LVAD implantation in Refractory Heart Failure, sponsored by BrioHealth BV.

Who is sponsoring NCT07252531?

NCT07252531 is sponsored by BrioHealth BV.

What drugs are being tested in NCT07252531?

Interventions in NCT07252531: LVAD implantation.

What condition does NCT07252531 study?

NCT07252531 studies Refractory Heart Failure, Cardiovascular Diseases (CVD).

Is NCT07252531 still recruiting?

NCT07252531 is currently not yet recruiting. Last updated 2 April 2026.

Last reviewed 2026-04-02 · How we verify

NCT07252531: BRIOLIFE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

European Study of the BrioVAD Heart Pump for Advanced Heart Failure

Not yet recruiting NA Last updated 2 April 2026

What this trial tests

NA trial testing LVAD implantation in Refractory Heart Failure in 60 participants. Not yet recruiting.

Timeline

15 May 2026

Primary endpoint
31 July 2027

31 January 2029

Quick facts

Lead sponsor	BrioHealth BV
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	15 May 2026
Primary completion	31 July 2027
Estimated completion	31 January 2029

Drugs / interventions tested

LVAD implantation

Conditions studied

Refractory Heart Failure — all drugs for Refractory Heart Failure →
Cardiovascular Diseases (CVD) — all drugs for Cardiovascular Diseases (CVD) →

Sponsor

BrioHealth BV

Who can join

18 and older, any sex, with Refractory Heart Failure or Cardiovascular Diseases (CVD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical investigation evaluates the safety and clinical performance of the BrioVAD Left Ventricular Assist System in patients with advanced, refractory left ventricular heart failure who require mechanical circulatory support.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Refractory Heart Failure

Currently open trials in the same condition.

NCT05876000 — Corheart 6 LVAS Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07252531 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by BrioHealth BV
Last refreshed: 2 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07252531.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing